Summary
Excess mortality,i.e. more deaths than expected in a similar normal population, has been reduced in Parkinson's disease by levodopa. A California series and a large collaborative study throughout the United States show the ratio of observed to expected deaths to be normal. In contrast, a New York study with similar patients and a Montreal group of much more severely disabled patients show greater mortality. The reasons for these differences are unclear, but some variation in results may be attributed to different methods of calculating expected deaths to derive the ratio of observed to expected deaths.
Similar content being viewed by others
References
Barbeau, A.: Six years of high-level levodopa therapy in severely akinetic parkinsonian patients. Arch. Neurol.33, 333–338 (1976).
Cotzias, G. C., Papavasiliou, P. S., Gellene, R.: Modification of parkinsonism—chronic treatment with L-dopa. N. Eng. J. Med.280, 337–345 (1969).
Diamond, S. G., Markham, C. H., Treciokas, L. J.: Long term experience with levodopa: efficacy, progression and mortality. Proc. Vth Int. Symp. Parkinson's Disease, Vienna 1975 (in press).
Hoehn, M. M., Yahr, M. D.: Parkinsonism: onset, progression and mortality. Neurology17, 427–442 (1967).
Kurland, L. T.: Epidemiology: incidence, geographic distribution and genetic considerations. In: Pathogenesis and Treatment of Parkinsonism (Field, W. S., ed.). Springfield, Ill.: Charles C Thomas. 1958.
Markham, C. H., Treciokas, L. J., Diamond, S. G.: Parkinson's disease and and levodopa—a five year follow up and review. West. J. Med.121, 188–206 (1974).
Sweet, R. D., McDowell, F. H.: Five years' treatment of Parkinson's disease with levodopa. Ann. Int. Med.83, 456–463 (1975).
U.S. Public Health Service: United States life tables. U.S. Department of Health, Education and Welfare, Washington, D.C., Vol. 1, No. 1, 1959 to 1960.
Yahr, M. D., Duvoisin, R. C., Hoehn, M. M., Schear, M. J., Barrett, R. E.: L-dopa (L-3,4-dihydroxyphenylalanine)—its clinical effects in parkinsonism. Trans. Am. Neurol. Assoc.93, 56–63 (1968).
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr.W. Birkmayer on the occasion of his 65th birthday.
The support of the Murdy Foundation and the Arthur Rosenberg Foundation is gratefully acknowledged.
Rights and permissions
About this article
Cite this article
Diamond, S.G., Markham, C.H. Present mortality in Parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths. J. Neural Transmission 38, 259–269 (1976). https://doi.org/10.1007/BF01249443
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249443